Results 151 to 160 of about 347,393 (310)
Attempts at vacuum counterexamples to cosmic censorship in AdS [PDF]
Toby Crisford +5 more
openalex +1 more source
High Altitude characterization of the Hunga Pressure Wave with Cosmic Rays by the HAWC Observatory [PDF]
R. Alfaro +66 more
openalex +1 more source
Reaction networks yielding spontaneous mirror‐symmetry breaking (SMSB) are revisited. All include a first‐order enantioselective autocatalysis, which, on its own, is unable to lead to SMSB. The coupling with the so‐called ancillary reactions (racemization, mutual inhibition, etc.) makes the racemic state unstable.
Josep M. Ribó +2 more
wiley +1 more source
Doppler term in the galaxy two-point correlation function: wide-angle,\n velocity, Doppler lensing and cosmic acceleration effects [PDF]
Alvise Raccanelli +4 more
openalex +1 more source
Slow diffusion around pulsar 𝜸-ray halos and its impact on cosmic rays propagation [PDF]
Xiao-Jun Bi
openalex +1 more source
The image illustrates a multi‐technique analysis of Islamic‐African manuscripts from the nineteenth to twentieth centuries. It highlights methods like microscopy, hyperspectral imaging, FTIR, LIF, Raman, LIBS, and furnish analysis used to study paper fibers, inks, and dyes—revealing a blend of local and trade materials and a rich fusion of Qur’anic and
Abdelrazek Elnaggar +12 more
wiley +1 more source
Potential contribution from gamma-ray sources to the Galactic diffuse gamma rays observed above 100 TeV (sub-PeV energy range) by the Tibet AS γ experiment is an important key to interpreting recent multimessenger observations.
S. Kato +10 more
doaj +1 more source
Cosmic acceleration and phantom crossing in f(T)-gravity [PDF]
Hossein Farajollahi, A. Ravanpak, P. Wu
openalex +1 more source
Can the angular scale of cosmic homogeneity be used as a cosmological test? [PDF]
Xiaoyun Shao +5 more
openalex +1 more source
Potential adverse drug events can be signaled in Clinical Decision Support Systems (CDSSs). This study validated a Swedish CDSS (Janusmed Risk Profile) by investigating associations between calculated risk classifications of drugs with QT‐prolonging potential and registered related clinical outcomes.
Ola Nordqvist +6 more
wiley +1 more source

